Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein

The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants...

Full description

Saved in:
Bibliographic Details
Published inVaccines (Basel) Vol. 11; no. 2; p. 399
Main Authors Umitaibatin, Ramadhita, Harisna, Azza Hanif, Jauhar, Muhammad Miftah, Syaifie, Putri Hawa, Arda, Adzani Gaisani, Nugroho, Dwi Wahyu, Ramadhan, Donny, Mardliyati, Etik, Shalannanda, Wervyan, Anshori, Isa
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.02.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study.
AbstractList The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study.
The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study.The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study.
Audience Academic
Author Ramadhan, Donny
Anshori, Isa
Syaifie, Putri Hawa
Nugroho, Dwi Wahyu
Harisna, Azza Hanif
Umitaibatin, Ramadhita
Shalannanda, Wervyan
Arda, Adzani Gaisani
Mardliyati, Etik
Jauhar, Muhammad Miftah
AuthorAffiliation 1 Lab-on-Chip Group, Department of Biomedical Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia
2 Nano Center Indonesia, Jl. Raya Puspiptek, South Tangerang 15314, Indonesia
5 Department of Telecommunication Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia
4 Research Center for Vaccine and Drug, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia
3 Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia
AuthorAffiliation_xml – name: 3 Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia
– name: 4 Research Center for Vaccine and Drug, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia
– name: 2 Nano Center Indonesia, Jl. Raya Puspiptek, South Tangerang 15314, Indonesia
– name: 5 Department of Telecommunication Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia
– name: 1 Lab-on-Chip Group, Department of Biomedical Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia
Author_xml – sequence: 1
  givenname: Ramadhita
  surname: Umitaibatin
  fullname: Umitaibatin, Ramadhita
– sequence: 2
  givenname: Azza Hanif
  surname: Harisna
  fullname: Harisna, Azza Hanif
– sequence: 3
  givenname: Muhammad Miftah
  orcidid: 0000-0002-5826-5904
  surname: Jauhar
  fullname: Jauhar, Muhammad Miftah
– sequence: 4
  givenname: Putri Hawa
  orcidid: 0000-0001-8566-7960
  surname: Syaifie
  fullname: Syaifie, Putri Hawa
– sequence: 5
  givenname: Adzani Gaisani
  orcidid: 0000-0002-2674-6295
  surname: Arda
  fullname: Arda, Adzani Gaisani
– sequence: 6
  givenname: Dwi Wahyu
  orcidid: 0000-0002-7020-8582
  surname: Nugroho
  fullname: Nugroho, Dwi Wahyu
– sequence: 7
  givenname: Donny
  orcidid: 0000-0001-6556-3160
  surname: Ramadhan
  fullname: Ramadhan, Donny
– sequence: 8
  givenname: Etik
  surname: Mardliyati
  fullname: Mardliyati, Etik
– sequence: 9
  givenname: Wervyan
  orcidid: 0000-0002-4342-9718
  surname: Shalannanda
  fullname: Shalannanda, Wervyan
– sequence: 10
  givenname: Isa
  orcidid: 0000-0001-5134-7264
  surname: Anshori
  fullname: Anshori, Isa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36851275$$D View this record in MEDLINE/PubMed
BookMark eNp1ksFv0zAUxi00xLayOycUiQuXDMdOHJsDUiljVBpCojBxwnLt5-KSxMFOJvW_n0vHWCuwD7bs3_ue3_N3io463wFCzwp8TqnAr26U1q6DWBSYYCrEI3RCcM1yKui3owf7Y3QW4xqnIQrKWf0EHVPGq4LU1Qn6Pm_bsfOusz60anA6ZothNJvX2cexGVx-0bvB95C9VRFMdr1Lmb2D6FZdZoNvs8X08yKf-eucZIve_YTsstlo3wc_gOueosdWNRHO7tYJ-vr-4svsQ3716XI-m17luqrqIedKU024UoYIhcEqbQlVjOHaYqBLosoSmKW0UFQvhSiAC9BK1EbbJRMJmaD5Ttd4tZZ9cK0KG-mVk78PfFhJFVJ1DciKE2MwZdZoXmohlGHADOPWcFKWKe8Evdlp9eOyBaOhG4Jq9kT3bzr3Q678jRSClTx1fIJe3gkE_2uEOMjWRQ1NozrwY5Sk5ulvCOM0oS8O0LUfQ5dalahaMCaoqP5SK5UK2P5Vyqu3onJal7QSnLLtu8__QaVpoHU6ece6dL4X8PxhofcV_nFHAvAO0MHHGMDeIwWWWw_KQw-mEHYQot2QfOW3rXLN_wNvAW-d4lY
CitedBy_id crossref_primary_10_1016_j_humimm_2024_111117
crossref_primary_10_3390_vaccines12040358
crossref_primary_10_1007_s40203_024_00288_z
crossref_primary_10_1016_j_jsps_2023_101917
crossref_primary_10_3389_fimmu_2024_1424307
crossref_primary_10_1016_j_heliyon_2024_e39142
crossref_primary_10_3390_biomedinformatics4020084
crossref_primary_10_1007_s12033_024_01303_6
crossref_primary_10_1007_s12033_024_01358_5
Cites_doi 10.1016/j.celrep.2021.108890
10.1016/j.imu.2020.100500
10.1007/s00894-014-2278-5
10.1371/journal.pone.0073957
10.3389/fimmu.2021.693775
10.7554/eLife.07454
10.1093/molbev/msy096
10.1038/s41591-021-01347-0
10.1016/j.autrev.2020.102556
10.1186/1745-6150-3-38
10.1016/j.jmb.2015.09.014
10.1097/BOR.0000000000000776
10.1038/nature07830
10.2807/1560-7917.ES.2017.22.13.30494
10.1016/j.autrev.2020.102591
10.1186/1471-2105-8-4
10.1186/1471-2105-8-424
10.1016/S0006-3495(03)74736-5
10.3390/microorganisms9071542
10.1016/j.drudis.2020.03.006
10.1002/pro.3289
10.3390/vaccines9121459
10.7554/eLife.61312
10.1038/s41401-020-0485-4
10.3389/fimmu.2022.1035924
10.1016/S1359-6101(02)00044-8
10.1021/acs.jproteome.9b00874
10.1073/pnas.0603245103
10.3390/antib9030033
10.1016/j.dsx.2020.04.020
10.1016/j.cell.2020.02.058
10.3389/fimmu.2018.02061
10.1016/j.ijbiomac.2012.06.005
10.1016/S0022-2836(63)80023-6
10.1186/1471-2105-9-514
10.3906/biy-2006-1
10.1016/j.medntd.2020.100048
10.1002/prot.22927
10.1038/s41586-020-2012-7
10.1093/nar/gkn860
10.1038/s41541-022-00597-4
10.1093/nar/gkx346
10.1093/protein/10.9.999
10.1016/j.biotechadv.2011.09.013
10.1002/pro.5560020916
10.1016/j.imu.2021.100781
10.1016/j.imbio.2020.151955
10.1002/JLB.4MIR0420-619RR
10.1016/j.chom.2021.02.003
10.1016/j.bpj.2016.04.015
10.2807/1560-7917.ES.2020.25.23.2001005
10.1093/bioinformatics/btw514
10.1093/bib/bbaa416
10.1016/j.ijbiomac.2020.06.213
10.1136/jclinpath-2020-206658
10.1016/j.cell.2020.08.012
10.1002/jmv.25700
10.1038/msb.2011.75
10.3389/fimmu.2021.621706
10.1515/bmc.2010.022
10.3389/fimmu.2021.646972
10.1111/j.1600-065X.2008.00707.x
10.1093/bioinformatics/btv639
10.1124/dmd.104.000794
10.1016/j.febslet.2014.05.006
10.3389/fmicb.2014.00172
10.1371/journal.pcbi.1006457
10.1016/j.cell.2020.06.043
10.1111/j.1476-5381.2010.01127.x
10.1371/journal.pone.0009862
10.1073/pnas.1914677117
10.1038/s41579-021-00573-0
10.1021/ja026939x
10.4161/bbug.2.3.15367
10.1107/S0021889892009944
10.3390/vaccines8020288
10.1038/cmi.2017.92
10.7554/eLife.58603
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
NPM
3V.
7T7
7XB
8FD
8FE
8FH
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
GNUQQ
GUQSH
HCIFZ
LK8
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
5PM
DOA
DOI 10.3390/vaccines11020399
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2076-393X
ExternalDocumentID oai_doaj_org_article_582dd036fdc84c99ad6e6d68fd8244f2
PMC9964839
A743598362
36851275
10_3390_vaccines11020399
Genre Journal Article
GeographicLocations Indonesia
GeographicLocations_xml – name: Indonesia
GrantInformation_xml – fundername: Bandung Institute of Technology
  grantid: ITB
– fundername: Bandung Institute of Technology (ITB)
GroupedDBID 53G
5VS
8FE
8FH
8G5
AADQD
AAHBH
AAYXX
ABUWG
ADBBV
AEUYN
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
NPM
PQGLB
PMFND
3V.
7T7
7XB
8FD
8FK
C1K
FR3
MBDVC
P64
PKEHL
PQEST
PQUKI
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c557t-8ac3c28aad29a0efacf23a6607f0e3b2a44e6f331a3cb991e89eca97dcfb690e3
IEDL.DBID BENPR
ISSN 2076-393X
IngestDate Wed Aug 27 01:31:39 EDT 2025
Thu Aug 21 18:37:56 EDT 2025
Fri Jul 11 01:10:13 EDT 2025
Sun Jul 13 05:22:04 EDT 2025
Tue Jun 17 22:13:45 EDT 2025
Tue Jun 10 21:15:14 EDT 2025
Mon Jul 21 05:44:24 EDT 2025
Tue Jul 01 01:10:58 EDT 2025
Thu Apr 24 23:06:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords epitope prediction
antigenic epitope
TLR-3
spike glycoprotein
LR-4
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c557t-8ac3c28aad29a0efacf23a6607f0e3b2a44e6f331a3cb991e89eca97dcfb690e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4342-9718
0000-0001-6556-3160
0000-0002-2674-6295
0000-0001-5134-7264
0000-0002-5826-5904
0000-0001-8566-7960
0000-0002-7020-8582
OpenAccessLink https://www.proquest.com/docview/2779669395?pq-origsite=%requestingapplication%
PMID 36851275
PQID 2779669395
PQPubID 2032320
ParticipantIDs doaj_primary_oai_doaj_org_article_582dd036fdc84c99ad6e6d68fd8244f2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9964839
proquest_miscellaneous_2780762683
proquest_journals_2779669395
gale_infotracmisc_A743598362
gale_infotracacademiconefile_A743598362
pubmed_primary_36851275
crossref_primary_10_3390_vaccines11020399
crossref_citationtrail_10_3390_vaccines11020399
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-02-01
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Vaccines (Basel)
PublicationTitleAlternate Vaccines (Basel)
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Chen (ref_82) 2012; 30
McCabe (ref_25) 2019; 48
Zhao (ref_12) 2022; 7
Laskowski (ref_51) 2017; 27
Mezouar (ref_81) 2020; 108
Bravo (ref_84) 2008; 3
Ahammad (ref_36) 2020; 162
Yang (ref_38) 2020; 117
ref_52
Su (ref_41) 1963; 7
Parvizpour (ref_14) 2020; 25
Sahoo (ref_46) 2012; 51
Dominguez (ref_43) 2003; 125
Greaney (ref_62) 2021; 29
ref_60
Pillay (ref_3) 2020; 73
Xu (ref_78) 1997; 10
Angileri (ref_68) 2020; 19
Laskowski (ref_40) 1993; 26
Kumar (ref_19) 2018; 35
Bowick (ref_9) 2011; 2
Park (ref_47) 2009; 458
Chesler (ref_64) 2002; 13
ref_23
Andreano (ref_63) 2021; 27
Donald (ref_74) 2010; 79
Xue (ref_48) 2016; 32
Muir (ref_57) 2021; 34
Li (ref_7) 2020; 8
Sarkar (ref_37) 2020; 225
Korber (ref_59) 2020; 182
ref_29
Starr (ref_58) 2020; 182
Harvey (ref_56) 2021; 19
Sanches (ref_71) 2021; 12
Williams (ref_28) 2004; 32
Castiglione (ref_53) 2021; 12
Sievers (ref_20) 2011; 7
Walls (ref_5) 2020; 181
Hu (ref_80) 2008; 226
Ahsan (ref_8) 2021; 22
Gustiananda (ref_16) 2021; 9
ref_72
Reynisson (ref_30) 2020; 19
ref_70
Shu (ref_18) 2017; 22
Anand (ref_67) 2020; 9
Huang (ref_6) 2020; 41
Febrianti (ref_17) 2022; 17
ref_35
Rodrigues (ref_44) 2016; 428
ref_33
Meuzelaar (ref_76) 2016; 110
ref_32
Laskowski (ref_50) 2009; 37
Vangone (ref_49) 2015; 4
ref_73
Dimitrov (ref_34) 2014; 20
Liu (ref_66) 2020; 33
Ceraolo (ref_1) 2020; 92
Acar (ref_10) 2020; 44
Hollingsworth (ref_39) 2010; 1
Yousaf (ref_13) 2022; 13
Andreatta (ref_24) 2015; 32
Saitou (ref_22) 1987; 4
White (ref_27) 2001; 29
Zhang (ref_15) 2017; 15
Ghosh (ref_75) 2003; 85
Astuti (ref_4) 2020; 14
Weisblum (ref_61) 2020; 9
Hughes (ref_26) 2011; 162
Colovos (ref_42) 1993; 2
Pace (ref_77) 2014; 588
Hossain (ref_54) 2020; 22
Lee (ref_65) 2018; 9
Jebin (ref_79) 2021; 27
Rosano (ref_83) 2014; 5
Zhou (ref_2) 2020; 579
Jespersen (ref_31) 2017; 45
Ding (ref_55) 2021; 12
Oreshkova (ref_11) 2020; 25
Jones (ref_21) 1992; 8
Bell (ref_45) 2006; 103
Lucchese (ref_69) 2020; 19
References_xml – volume: 34
  start-page: 108890
  year: 2021
  ident: ref_57
  article-title: The Effect of Spike Mutations on SARS-CoV-2 Neutralization
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2021.108890
– volume: 22
  start-page: 100500
  year: 2020
  ident: ref_54
  article-title: Immunoinformatics approach to designing a multi-epitope vaccine against Saint Louis Encephalitis Virus
  publication-title: Informatics Med. Unlocked
  doi: 10.1016/j.imu.2020.100500
– volume: 20
  start-page: 2278
  year: 2014
  ident: ref_34
  article-title: AllerTOP v. 2—A Server for in Silico Prediction of Allergens
  publication-title: J. Mol. Model
  doi: 10.1007/s00894-014-2278-5
– ident: ref_35
  doi: 10.1371/journal.pone.0073957
– volume: 12
  start-page: 3231
  year: 2021
  ident: ref_55
  article-title: Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.693775
– volume: 29
  start-page: 957
  year: 2001
  ident: ref_27
  article-title: Pharmacokinetic theory of cassette dosing in drug discovery screening
  publication-title: Drug Metab. Dispos.
– volume: 4
  start-page: e07454
  year: 2015
  ident: ref_49
  article-title: Contacts-based prediction of binding affinity in protein–protein complexes
  publication-title: Elife
  doi: 10.7554/eLife.07454
– volume: 35
  start-page: 1547
  year: 2018
  ident: ref_19
  article-title: MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msy096
– volume: 27
  start-page: 759
  year: 2021
  ident: ref_63
  article-title: SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01347-0
– volume: 19
  start-page: 102556
  year: 2020
  ident: ref_69
  article-title: Molecular Mimicry between SARS-CoV-2 and Respiratory Pacemaker Neurons
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102556
– volume: 3
  start-page: 38
  year: 2008
  ident: ref_84
  article-title: CAIcal: A combined set of tools to assess codon usage adaptation
  publication-title: Biol. Direct
  doi: 10.1186/1745-6150-3-38
– volume: 428
  start-page: 720
  year: 2016
  ident: ref_44
  article-title: The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2015.09.014
– volume: 33
  start-page: 155
  year: 2020
  ident: ref_66
  article-title: COVID-19 and autoimmune diseases
  publication-title: Curr. Opin. Rheumatol.
  doi: 10.1097/BOR.0000000000000776
– volume: 458
  start-page: 1191
  year: 2009
  ident: ref_47
  article-title: The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
  publication-title: Nature
  doi: 10.1038/nature07830
– volume: 22
  start-page: 30494
  year: 2017
  ident: ref_18
  article-title: GISAID: Global Initiative on Sharing All Influenza Data–from Vision to Reality
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2017.22.13.30494
– volume: 19
  start-page: 102591
  year: 2020
  ident: ref_68
  article-title: Molecular mimicry may explain multi-organ damage in COVID-19
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102591
– ident: ref_33
  doi: 10.1186/1471-2105-8-4
– ident: ref_23
  doi: 10.1186/1471-2105-8-424
– volume: 85
  start-page: 3187
  year: 2003
  ident: ref_75
  article-title: Role of Backbone Hydration and Salt-Bridge Formation in Stability of α-Helix in Solution
  publication-title: Biophys. J.
  doi: 10.1016/S0006-3495(03)74736-5
– volume: 48
  start-page: D783
  year: 2019
  ident: ref_25
  article-title: Allele frequency net database (AFND) 2020 update: Gold-standard data classification, open access genotype data and new query tools
  publication-title: Nucleic Acids Res.
– ident: ref_60
  doi: 10.3390/microorganisms9071542
– volume: 25
  start-page: 1034
  year: 2020
  ident: ref_14
  article-title: Epitope-based vaccine design: A comprehensive overview of bioinformatics approaches
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2020.03.006
– volume: 27
  start-page: 129
  year: 2017
  ident: ref_51
  article-title: PDBsum: Structural summaries of PDB entries
  publication-title: Protein Sci.
  doi: 10.1002/pro.3289
– volume: 9
  start-page: 1459
  year: 2021
  ident: ref_16
  article-title: Immunoinformatics Analysis of SARS-CoV-2 ORF1ab Polyproteins to Identify Promiscuous and Highly Conserved T-Cell Epitopes to Formulate Vaccine for Indonesia and the World Population
  publication-title: Vaccines
  doi: 10.3390/vaccines9121459
– volume: 9
  start-page: e61312
  year: 2020
  ident: ref_61
  article-title: Escape from Neutralizing Antibodies by SARS-CoV-2 Spike Protein Variants
  publication-title: Elife
  doi: 10.7554/eLife.61312
– volume: 41
  start-page: 1141
  year: 2020
  ident: ref_6
  article-title: Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19
  publication-title: Acta Pharm. Sin.
  doi: 10.1038/s41401-020-0485-4
– volume: 13
  start-page: 1035924
  year: 2022
  ident: ref_13
  article-title: Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2022.1035924
– volume: 13
  start-page: 441
  year: 2002
  ident: ref_64
  article-title: The role of IFN-γ in immune responses to viral infections of the central nervous system
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/S1359-6101(02)00044-8
– volume: 19
  start-page: 2304
  year: 2020
  ident: ref_30
  article-title: Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data
  publication-title: J. Proteome Res.
  doi: 10.1021/acs.jproteome.9b00874
– volume: 103
  start-page: 8792
  year: 2006
  ident: ref_45
  article-title: The dsRNA binding site of human Toll-like receptor 3
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0603245103
– ident: ref_70
  doi: 10.3390/antib9030033
– volume: 14
  start-page: 407
  year: 2020
  ident: ref_4
  article-title: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response
  publication-title: Diabetes Metab. Syndr. Clin. Res. Rev.
  doi: 10.1016/j.dsx.2020.04.020
– volume: 181
  start-page: 281
  year: 2020
  ident: ref_5
  article-title: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.058
– volume: 9
  start-page: 2061
  year: 2018
  ident: ref_65
  article-title: The Dual Nature of Type I and Type II Interferons
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.02061
– volume: 51
  start-page: 531
  year: 2012
  ident: ref_46
  article-title: Structural insights of rohu TLR3, its binding site analysis with fish reovirus dsRNA, poly I:C and zebrafish TRIF
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2012.06.005
– volume: 7
  start-page: 95
  year: 1963
  ident: ref_41
  article-title: Stereochemistry of Polypeptide Chain Configurations
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(63)80023-6
– ident: ref_32
  doi: 10.1186/1471-2105-9-514
– volume: 44
  start-page: 215
  year: 2020
  ident: ref_10
  article-title: An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19
  publication-title: Turk. J. Biol.
  doi: 10.3906/biy-2006-1
– volume: 8
  start-page: 100048
  year: 2020
  ident: ref_7
  article-title: Spike Protein-Based Epitopes Predicted against SARS-CoV-2 through Literature Mining
  publication-title: Med. Nov. Technol. Devices
  doi: 10.1016/j.medntd.2020.100048
– ident: ref_72
– volume: 79
  start-page: 898
  year: 2010
  ident: ref_74
  article-title: Salt bridges: Geometrically specific, designable interactions
  publication-title: Proteins Struct. Funct. Bioinform.
  doi: 10.1002/prot.22927
– volume: 579
  start-page: 270
  year: 2020
  ident: ref_2
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
– volume: 37
  start-page: D355
  year: 2009
  ident: ref_50
  article-title: PDBsum New Things
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkn860
– volume: 7
  start-page: 167
  year: 2022
  ident: ref_12
  article-title: Challenges and Developments in Universal Vaccine Design against SARS-CoV-2 Variants
  publication-title: NPJ Vaccines
  doi: 10.1038/s41541-022-00597-4
– volume: 45
  start-page: W24
  year: 2017
  ident: ref_31
  article-title: BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkx346
– volume: 10
  start-page: 999
  year: 1997
  ident: ref_78
  article-title: Hydrogen bonds and salt bridges across protein-protein interfaces
  publication-title: Protein Eng. Des. Sel.
  doi: 10.1093/protein/10.9.999
– volume: 30
  start-page: 1102
  year: 2012
  ident: ref_82
  article-title: Bacterial expression systems for recombinant protein production: E. coli and beyond
  publication-title: Biotechnol. Adv.
  doi: 10.1016/j.biotechadv.2011.09.013
– volume: 2
  start-page: 1511
  year: 1993
  ident: ref_42
  article-title: Verification of protein structures: Patterns of nonbonded atomic interactions
  publication-title: Protein Sci.
  doi: 10.1002/pro.5560020916
– volume: 27
  start-page: 100781
  year: 2021
  ident: ref_79
  article-title: Development of an in silico multi-epitope vaccine against SARS-CoV-2 by précised immune-informatics approaches
  publication-title: Inform. Med. Unlocked
  doi: 10.1016/j.imu.2021.100781
– volume: 225
  start-page: 151955
  year: 2020
  ident: ref_37
  article-title: Immunoinformatics-Guided Designing of Epitope-Based Subunit Vaccines against the SARS Coronavirus-2 (SARS-CoV-2)
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2020.151955
– volume: 108
  start-page: 419
  year: 2020
  ident: ref_81
  article-title: Changing the paradigm of IFN-γ at the interface between innate and adaptive immunity: Macrophage-derived IFN-γ
  publication-title: J. Leukoc. Biol.
  doi: 10.1002/JLB.4MIR0420-619RR
– volume: 29
  start-page: 463
  year: 2021
  ident: ref_62
  article-title: Comprehensive Mapping of Mutations in the SARS-CoV-2 Receptor-Binding Domain That Affect Recognition by Polyclonal Human Plasma Antibodies
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2021.02.003
– volume: 110
  start-page: 2328
  year: 2016
  ident: ref_76
  article-title: Influence of Glu/Arg, Asp/Arg, and Glu/Lys Salt Bridges on α-Helical Stability and Folding Kinetics
  publication-title: Biophys. J.
  doi: 10.1016/j.bpj.2016.04.015
– volume: 25
  start-page: 2001005
  year: 2020
  ident: ref_11
  article-title: SARS-CoV-2 Infection in Farmed Minks, The Netherlands, April and May 2020
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2020.25.23.2001005
– volume: 8
  start-page: 275
  year: 1992
  ident: ref_21
  article-title: The rapid generation of mutation data matrices from protein sequences
  publication-title: Comput. Appl. Biosci.
– volume: 32
  start-page: 3676
  year: 2016
  ident: ref_48
  article-title: PRODIGY: A web server for predicting the binding affinity of protein–protein complexes
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btw514
– volume: 22
  start-page: 714
  year: 2021
  ident: ref_8
  article-title: Bioinformatics Resources Facilitate Understanding and Harnessing Clinical Research of SARS-CoV-2
  publication-title: Brief Bioinform.
  doi: 10.1093/bib/bbaa416
– volume: 162
  start-page: 820
  year: 2020
  ident: ref_36
  article-title: Designing a Novel MRNA Vaccine against SARS-CoV-2: An Immunoinformatics Approach
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2020.06.213
– volume: 73
  start-page: 366
  year: 2020
  ident: ref_3
  article-title: Gene of the Month: The 2019-NCoV/SARS-CoV-2 Novel Coronavirus Spike Protein
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jclinpath-2020-206658
– volume: 182
  start-page: 1295
  year: 2020
  ident: ref_58
  article-title: Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
  publication-title: Cell
  doi: 10.1016/j.cell.2020.08.012
– volume: 92
  start-page: 522
  year: 2020
  ident: ref_1
  article-title: Genomic variance of the 2019-nCoV coronavirus
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25700
– volume: 7
  start-page: 539
  year: 2011
  ident: ref_20
  article-title: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
  publication-title: Mol. Syst. Biol.
  doi: 10.1038/msb.2011.75
– volume: 12
  start-page: 621706
  year: 2021
  ident: ref_71
  article-title: Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.621706
– volume: 1
  start-page: 271
  year: 2010
  ident: ref_39
  article-title: A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins
  publication-title: Biomol. Concepts
  doi: 10.1515/bmc.2010.022
– volume: 12
  start-page: 3433
  year: 2021
  ident: ref_53
  article-title: From Infection to Immunity: Understanding the Response to SARS-CoV2 through in-Silico Modeling
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2021.646972
– volume: 226
  start-page: 41
  year: 2008
  ident: ref_80
  article-title: Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2008.00707.x
– volume: 32
  start-page: 511
  year: 2015
  ident: ref_24
  article-title: Gapped sequence alignment using artificial neural networks: Application to the MHC class I system
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv639
– volume: 32
  start-page: 1201
  year: 2004
  ident: ref_28
  article-title: Drug-drug interactions for udp-glucuronosyltransferase substrates: A pharmacokinetic explanation for typically observed low exposure (auci/auc) ratios
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.104.000794
– volume: 588
  start-page: 2177
  year: 2014
  ident: ref_77
  article-title: Forces stabilizing proteins
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2014.05.006
– volume: 17
  start-page: 467
  year: 2022
  ident: ref_17
  article-title: In-Silico Analysis of Recombinant Protein Vaccines Based on the Spike Protein of Indonesian SARS-CoV-2 through a Reverse Vaccinology Approach
  publication-title: J. Taibah Univ. Med. Sci.
– volume: 5
  start-page: 172
  year: 2014
  ident: ref_83
  article-title: Recombinant protein expression in Escherichia coli: Advances and challenges
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2014.00172
– ident: ref_29
  doi: 10.1371/journal.pcbi.1006457
– volume: 182
  start-page: 812
  year: 2020
  ident: ref_59
  article-title: Tracking Changes in SARS-CoV-2 Spike: Evidence That D614G Increases Infectivity of the COVID-19 Virus
  publication-title: Cell
  doi: 10.1016/j.cell.2020.06.043
– volume: 162
  start-page: 1239
  year: 2011
  ident: ref_26
  article-title: Principles of early drug discovery
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2010.01127.x
– ident: ref_52
  doi: 10.1371/journal.pone.0009862
– volume: 4
  start-page: 406
  year: 1987
  ident: ref_22
  article-title: The neighbor-joining method: A new method for reconstructing phylogenetic trees
  publication-title: Mol. Biol. Evol.
– volume: 117
  start-page: 1496
  year: 2020
  ident: ref_38
  article-title: Improved protein structure prediction using predicted interresidue orientations
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1914677117
– volume: 19
  start-page: 409
  year: 2021
  ident: ref_56
  article-title: SARS-CoV-2 Variants, Spike Mutations and Immune Escape
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/s41579-021-00573-0
– volume: 125
  start-page: 1731
  year: 2003
  ident: ref_43
  article-title: HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja026939x
– volume: 2
  start-page: 129
  year: 2011
  ident: ref_9
  article-title: Vaccine and Adjuvant Design for Emerging Viruses: Mutations, Deletions, Segments and Signaling
  publication-title: Bioeng. Bugs
  doi: 10.4161/bbug.2.3.15367
– volume: 26
  start-page: 283
  year: 1993
  ident: ref_40
  article-title: PROCHECK: A program to check the stereochemical quality of protein structures
  publication-title: J. Appl. Crystallogr.
  doi: 10.1107/S0021889892009944
– ident: ref_73
  doi: 10.3390/vaccines8020288
– volume: 15
  start-page: 182
  year: 2017
  ident: ref_15
  article-title: Multi-epitope vaccines: A promising strategy against tumors and viral infections
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/cmi.2017.92
– volume: 9
  start-page: e58603
  year: 2020
  ident: ref_67
  article-title: SARS-CoV-2 Strategically Mimics Proteolytic Activation of Human ENaC
  publication-title: Elife
  doi: 10.7554/eLife.58603
SSID ssj0000913867
Score 2.2688856
Snippet The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 399
SubjectTerms Amino acids
Antibodies
Antigenic determinants
antigenic epitope
Antigens
Binding sites
CD4 antigen
CD8 antigen
Coronaviruses
COVID-19
COVID-19 vaccines
Cytotoxicity
Design
Dynamic stability
epitope prediction
Epitopes
Glycoproteins
Health aspects
LR-4
Lymphocytes
Lymphocytes B
Lymphocytes T
Molecular docking
Molecular dynamics
Mutation
Phylogenetics
Population
Proteins
Severe acute respiratory syndrome coronavirus 2
Side effects
Simulation
Spike glycoprotein
Spike protein
TLR-3
Vaccines
Vectors (Biology)
Viral diseases
Viral infections
γ-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQnnhBfBMYyEhoCGlWXTvxB2_d2BhIoIlu056I_CkqpqSiHVL_e85O1jYgwQsPeakvUew73--uufsZoVeecltZE4jTkRNweJRYcAlkbK3gpoox5j_cPn0WJ-flx8vqcuuor1QT1tEDdws3qhTz8EARvVOl09p4EYQXKnoFyBSz9wXM20qmsg_WY66E7L5LcsjrRz-NS1-qFwB3jPJM9brBoUzX_6dT3kKlYcXkFgQd30V3-tgRT7p3voduheY-2jvtyKdX-_hs00u12Md7-HRDS716gL5-SK0gbc-UmmRwKiJcvcW5CZcczWFzzwM-AFzz-KKbCH6XKzxw6kLB08mXKTlsLwjD0_nse8Dvr1auzUwPs-YhOj8-Ojs8If3pCsRVlVwSZRx3TBnjmTY0ROMi40YIKiMN3DJTlkFEzseGOwtRZFA6OKOld9FCSh34I7TTtE14gjCrQK2cUWG0LmXg2nlJSyfgitwJW6DRzVrXrqceTydgXNWQgiTt1L9rp0Bv1nfMO9qNv8geJPWt5RJhdv4BzKjuzaj-lxkV6HVSfp2UAK_mTN-dABNMBFn1BCKtSiuA-wLtDiRhO7rh8I351L07WNRMSkgrNddVgV6uh9OdqcStCe11klEUkEkoXqDHnbWtp5ROCUhM_AWSAzsczHk40sy-ZbJwyGdLCIKf_o9FeoZuM4jxuqL1XbSz_HEdnkNMtrQv8vb7BXaGOFY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgvPCC-CYwkJHQENLMUjvxBxJC3dgYSEMTXac9LfInVFRJaTtE_3vOSdouMO0hL_FZinN3vt8ldz8j9MqlzORGe2JVYAQ2vJQY2BJIzxjOdB5CqD-4HX3lh8Psy1l-tm6Pbl_g7MrULp4nNZyO3_75tfgADv8-ZpyQsu_81jb-hJ5BJKMpBNyb6BbEJRHd9KgF-_W-rHpMctH8q7xyYic21RT-_2_UlyJVt4ryUlg6uIvutHgS9xsDuIdu-PI-2jpuCKkX2_hk3V8128Zb-HhNVb14gM4_x_aQqmVPjTI4FhYu3uG6MZfsT8DhJx7vQqxz-LRZCP5YV33g2JmCB_1vA7JXnRKKB5PRT48_jRe2qtkfRuVDNDzYP9k7JO2JC8TmuZgTqS2zVGrtqNKpD9oGyjTnqQipZ4bqLPM8MNbTzBpAll4qb7USzgYDabZnj9BGWZX-CcI0B1UzmnKtVCY8U9aJNLMcrsAsNwnaWb7rwrZ05PFUjHEBaUnUTvGvdhL0ZjVj0lBxXCO7G9W3kosk2vWNavq9aH2yyCV1YKs8OCszq5R23HPHZXASQE-gCXodlV9EJcCjWd12LMACI2lW0Qf0lSsJECBBmx1JcFHbHV6aT7G08IIKAammYipP0MvVcJwZy95KX11EGZlCtOKSJehxY22rJcWTAyI7f4JExw47a-6OlKMfNYE45LgZAOOn1z_WM3SbAqJrStQ30cZ8euGfAwKbmxe1Y_0FeJcziA
  priority: 102
  providerName: Scholars Portal
Title Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
URI https://www.ncbi.nlm.nih.gov/pubmed/36851275
https://www.proquest.com/docview/2779669395
https://www.proquest.com/docview/2780762683
https://pubmed.ncbi.nlm.nih.gov/PMC9964839
https://doaj.org/article/582dd036fdc84c99ad6e6d68fd8244f2
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge-EF8U1gTJ6EhpBmNbMTx-YFtVvHQNpUrdu0JyLHH1AxJWHtkPrfc07cdAFpD-1DfZHi3vm-fPc7hN6bmBVpoSzR0jECCi8mBagEsl8UnKnUOdck3E5O-fFF8u0qvQoJt3koq1zpxEZRm0r7HPmAZhl45pLJ9HP9m_ipUf52NYzQeIg2QQULCL42R-PTyVmXZfGol4Jn7f0kg_h-8Edpf2M9B7NHY9ZAvq7tUQPb_79yvmOd-pWTd0zR0RP0OPiQeNgy_Sl6YMtnaHfSglAv9_D5uqdqvod38WQNT718jr5_9S0hVUBM9TTYFxMuP-GmGZeMazjktcUjsG8GX7YbwYdNpQf23Sh4OjybkoPqklA8rWe_LP5yvdRVg_gwK1-gi6Px-cExCVMWiE7TbEGE0kxToZShUsXWKe0oU5zHmYstK6hKEssdY_uK6QK8SSuk1UpmRrsCQmvLXqKNsirta4RpCuxlNOZKyiSzTGqTxYnm8HFM8yJCg9V_nesAQe4nYVznEIp47uT_cidCH7sn6hZ-4x7akWdfR-eBs5sfqpsfeTiHeSqoAfnkzmiRaCmV4ZYbLpwR4Og4GqEPnvm5ZwK8mlahSwE26IGy8iF4XKkUYPYjtNWjhGOp-8sr8cmDWpjnayGO0E637J_0pW6lrW49jYjBQnHBIvSqlbZuS35agEfkj1DWk8Penvsr5exnAxoOcW0CzvCb-1_rLXpEwYtry9K30Mbi5ta-A69rUWyHo7XdZC3g-yQRfwEZqDKM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N7gFeEN8LDDASDCEtamYnToyEULt1tGyrqrWb9kRwHBsqpqSsHaj_FH8j5yRtF5D2toe8xJcozp3vw777HcDr1GNJkEjtKmGYiwrPcxNUCe5OknAmA2NMseF21OfdE__zWXC2Bn8WtTA2rXKhEwtFnebK7pE3aRiiZy6YCD5Ofrq2a5Q9XV200CjF4kDPf2PINv3Q20P-vqF0vzPa7bpVVwFXBUE4cyOpmKKRlCkV0tNGKkOZ5NwLjadZQqXva24Y25FMJeg96UhoJUWYKpNgKKkZvvcWrPsMQ5kGrLc7_cHxclfHomxGPCzPQxkTXvOXVPaEfIpmlnqsgJhd2b-iTcD_xuCKNaxnal4xffv34G7ls5JWKWT3YU1nD2BrUIJez7fJaFXDNd0mW2SwgsOeP4QvPVuCklcIrZaG2OTF-XtSFP-6nQkqlYkmbbSnKTktJ0L2iswSYqtfyLB1PHR381OXkuFk_EOTT-dzlRcIE-PsEZzcyP9_DI0sz_QGEBqgODHqcSmEH2omVBp6vuJ4GaZ44kBz8a9jVUGe284b5zGGPpY78b_cceDd8olJCfdxDW3bsm9JZ4G6ixv5xbe4WvdxENEU1wM3qYp8JYRMueYpj0waoWNlqANvLfNjywT8NCWrqgicoAXmilvo4QUiQjfDgc0aJaoBVR9eiE9cqaFpvFo0DrxaDtsnbWpdpvNLSxN5aBF5xBx4Ukrbckq2O4HtAOBAWJPD2pzrI9n4ewFSjnG0j8730-s_6yXc7o6ODuPDXv_gGdyh6EGWKfGb0JhdXOrn6PHNkhfVMiPw9aZX9l-tnm_6
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTkK8IBgfCwxmJBhCWtTMTpwYCaF2bVkZVNW6TXsiOI4NFVNS1g7Uf42_jnOStgtIe9tDXuJLFOfO92Hf_Q7gZeqxJEikdpUwzEWF57kJqgR3L0k4k4Expthw-zzgByf-x7PgbA3-LGphbFrlQicWijrNld0jb9IwRM9cMBE0TZUWMez03k9-uraDlD1pXbTTKEXkUM9_Y_g2fdfvIK9fUdrrHu8fuFWHAVcFQThzI6mYopGUKRXS00YqQ5nk3AuNp1lCpe9rbhjbk0wl6EnpSGglRZgqk2BYqRm-9xashxgVeQ1Yb3cHw6PlDo9F3Ix4WJ6NMia85i-p7Gn5FE0u9VgBN7uyhUXLgP8NwxXLWM_avGIGe_fgbuW_klYpcPdhTWcbsDMsAbDnu-R4Vc813SU7ZLiCxp4_gC99W46SV2itlobYRMb5W1IUArvdCSqYiSZttK0pOS0nQjpFlgmxlTBk1Doaufv5qUvJaDL-ocmH87nKC7SJcfYQTm7k_z-CRpZnehMIDVC0GPW4FMIPNRMqDT1fcbwMUzxxoLn417Gq4M9tF47zGMMgy534X-448Gb5xKSE_riGtm3Zt6SzoN3FjfziW1zpgDiIaIprg5tURb4SQqZc85RHJo3QyTLUgdeW-bFlAn6aklWFBE7QgnTFLfT2AhGhy-HAVo0SVYKqDy_EJ65U0jReLSAHXiyH7ZM2zS7T-aWliTy0jjxiDjwupW05JdupwHYDcCCsyWFtzvWRbPy9ACzHmNpHR_zJ9Z-1DbdxRcef-oPDp3CHojNZZsdvQWN2camfofM3S55Xq4zA15te2H8BjkF0Lw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunoinformatics+Study%3A+Multi-Epitope+Based+Vaccine+Design+from+SARS-CoV-2+Spike+Glycoprotein&rft.jtitle=Vaccines+%28Basel%29&rft.au=Umitaibatin%2C+Ramadhita&rft.au=Harisna%2C+Azza+Hanif&rft.au=Jauhar%2C+Muhammad+Miftah&rft.au=Syaifie%2C+Putri+Hawa&rft.date=2023-02-01&rft.pub=MDPI+AG&rft.eissn=2076-393X&rft.volume=11&rft.issue=2&rft.spage=399&rft_id=info:doi/10.3390%2Fvaccines11020399&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon